Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
Critical priority
What you should do
- 1Contact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada.
- 2Continue taking your medication unless you have been advised to stop by your health care provider.
- 3Not treating your condition poses a greater health risk.
- 4Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall.
- 5Report any health product-related side effects or complaints to Health Canada.
The issue
Contamination
Affected product
Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.